This reduces the risk of hypoglycaemia compared to some other diabetes treatments, although the risk increases when used with insulin or sulfonylureas
For type 2 diabetes, NICE guidance (NG28) recommends their use as second- or third-line therapy when metformin alone provides inadequate control, particularly in patients who would benefit from weight loss or where hypoglycaemia risk must be minimised
If you look at the Biggest Loser studies, you see excessive dieting and exercise that initially produces weight loss but what does extreme calorie restriction ultimately do
It is not derived from an FDA-mandated label requirement, since no such requirement exists for this combination
It includes: exercising regularly reducing the strain on your affected joints staying at a healthy weight taking painkillers in more severe cases, joint replacement surgery
Does it follow USP sterile compounding standards